
Pubmed-entry ::= {
  pmid 29110042,
  medent {
    em std {
      year 2017,
      month 11,
      day 8,
      hour 6,
      minute 0
    },
    cit {
      title {
        name "[Acne inversa/hidradenitis suppurativa: A challenge for the
 future].",
        trans "Acne inversa/Hidradenitis suppurativa: Eine Herausforderung fur
 die Zukunft."
      },
      authors {
        names std {
          {
            name ml "Sabat R",
            affil str "Interdisziplinare Gruppe Molekulare Immunpathologie,
 Dermatologie/Med. Immunologie, Charite - Universitatsmedizin Berlin,
 Chariteplatz 1, 10117, Berlin, Deutschland. robert.sabat@charite.de.;
 Psoriasis Forschungs- und BehandlungsCentrum, Klinik fur Dermatologie,
 Venerologie und Allergologie und Institut fur Medizinische Immunologie,
 Charite - Universitatsmedizin Berlin, Chariteplatz 1, 10117, Berlin,
 Deutschland. robert.sabat@charite.de."
          }
        }
      },
      from journal {
        title {
          iso-jta "Hautarzt",
          ml-jta "Hautarzt",
          issn "1432-1173",
          name "Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und
 verwandte Gebiete"
        },
        imp {
          date std {
            year 2017,
            month 12
          },
          volume "68",
          issue "12",
          pages "994-998",
          language "ger",
          pubstatus ppublish,
          history {
            {
              pubstatus pubmed,
              date std {
                year 2017,
                month 11,
                day 8,
                hour 6,
                minute 0
              }
            },
            {
              pubstatus medline,
              date std {
                year 2019,
                month 2,
                day 8,
                hour 6,
                minute 0
              }
            },
            {
              pubstatus other,
              date std {
                year 2017,
                month 11,
                day 8,
                hour 6,
                minute 0
              }
            }
          }
        }
      },
      ids {
        pubmed 29110042,
        doi "10.1007/s00105-017-4079-0",
        pii "10.1007/s00105-017-4079-0",
        other {
          db "ELocationID doi",
          tag str "10.1007/s00105-017-4079-0"
        }
      }
    },
    abstract "Acne inversa (AI)/hidradenitis suppurativa is a chronic
 recurrent inflammatory dermatosis with signs of a systemic disease. AI is
 characterized by typical skin alterations in body areas bearing apocrine
 glands. The care of the AI patients in Germany is still inadequate. This
 situation might be significantly improved through the following efforts: (i)
 shortening of the time between the disease onset and the diagnosis/start of
 therapy; (ii) the in-depth investigation of AI pathogenesis with the aim of
 identifying innovative therapeutic targets and blood biomarkers; (iii)
 establishing a method for quantifying the severity of the disease, which
 takes into account both the clinical assessment and objective laboratory
 parameters and the self-assessment of the patient (e.g., Dermatology Life
 Quality Index [DLQI]); (iv) the elaboration of a clear algorithm for the
 interdisciplinary treatment of patients, which, in addition to the therapy of
 skin lesions, also includes lifestyle-modification measures and takes into
 consideration the systemic character of AI. This article describes the
 current problems of medical care for AI patients and outlines how we can
 achieve the predetermined goals.",
    mesh {
      {
        term "Algorithms"
      },
      {
        term "Anti-Bacterial Agents",
        qual {
          {
            subh "therapeutic use"
          }
        }
      },
      {
        term "Biomarkers",
        qual {
          {
            subh "blood"
          }
        }
      },
      {
        term "Diagnosis, Differential"
      },
      {
        term "Hidradenitis Suppurativa",
        qual {
          {
            subh "classification"
          },
          {
            subh "diagnosis"
          },
          {
            subh "etiology"
          },
          {
            mp TRUE,
            subh "therapy"
          }
        }
      },
      {
        term "Interdisciplinary Communication"
      },
      {
        term "Interleukins",
        qual {
          {
            subh "blood"
          }
        }
      },
      {
        term "Intersectoral Collaboration"
      },
      {
        term "Metabolic Syndrome",
        qual {
          {
            subh "blood"
          },
          {
            subh "diagnosis"
          }
        }
      },
      {
        term "Quality of Life"
      },
      {
        term "Risk Factors"
      },
      {
        term "Spondylarthropathies",
        qual {
          {
            subh "blood"
          },
          {
            subh "diagnosis"
          }
        }
      },
      {
        term "Tumor Necrosis Factor-alpha",
        qual {
          {
            subh "blood"
          }
        }
      }
    },
    substance {
      {
        type nameonly,
        name "Anti-Bacterial Agents"
      },
      {
        type nameonly,
        name "Biomarkers"
      },
      {
        type nameonly,
        name "Interleukins"
      },
      {
        type nameonly,
        name "TNF protein, human"
      },
      {
        type nameonly,
        name "Tumor Necrosis Factor-alpha"
      },
      {
        type cas,
        cit "XEO71E2E45",
        name "interleukin-22"
      }
    },
    pmid 29110042,
    pub-type {
      "Journal Article",
      "Review"
    },
    status medline
  }
}


